Robin Dalal

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 89 citations · Full text

Inflammation, Anti-inflammatory, Immunology +7

Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease

Nisha Shah, Jennifer Haydek, James C. Slaughter et al. · Inflammatory Bowel Diseases · 2019 · 40 citations · Full text

Identification and multimodal characterization of a specialized epithelial cell type associated with Crohn’s disease

Jia Li, Alan J. Simmons, Caroline V. Hawkins et al. · Nature Communications · 2024 · 38 citations · Full text

Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease

Alexis P. Calloway, Robin Dalal, Dawn B. Beaulieu et al. · Digestive Diseases and Sciences · 2017 · 28 citations

Inflammation, Psychological Co-morbidities, Functional Gastrointestinal Disorder +8

A patient education intervention improved rates of successful video visits during rapid implementation of telehealth

Roman E Gusdorf, Kaustav P. Shah, Austin J. Triana et al. · Journal of Telemedicine and Telecare · 2021 · 24 citations